Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to CU20100210ApriorityCriticalpatent/CU20100210A7/en
Publication of CU20100210A7publicationCriticalpatent/CU20100210A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Hydrogenated Pyridines
(AREA)
Abstract
Se desvelan compuestos y sales farmacéuticamente aceptables de los compuestos, teniendo los compuestos la estructura de fórmula I ESPACIO PARA LA FÓRMULA como se define en la memoria descriptiva. También se desvelan composiciones farmacéuticas, procedimientos de tratamiento, procedimientos de síntesis e intermedios correspondientes.Compounds and pharmaceutically acceptable salts of the compounds are disclosed, the compounds having the structure of formula I SPACE FOR FORMULA as defined in the specification. Pharmaceutical compositions, treatment procedures, synthesis procedures and corresponding intermediates are also disclosed.
CU20100210A2010-10-282010-10-28
NEW CLASS OF PIPERIDINES ESPIRO FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
CU20100210A7
(en)